
Pharmacologist focused on effects of cannabis / cannabinoids. Director of UCLA's Center for Cannabis and Cannabinoids @UCLACannabis
- Tweets582
- Following250
- Followers3.4K
- Likes2.5K

ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "Rescheduling can accomplish its primary purpose of generating clinically meaningful data only if Congress and the executive branch allocate more funding for doing that work." The Perspective is titled "Marijuana Rescheduling — A Game Changer for Research?" and the authors are Rebecca L. Haffajee, J.D., Ph.D., M.P.H., Robert A. Mikos, J.D., and Ziva D. Cooper, Ph.D. The text is displayed on a simple white background with a brown border. The NEJM identity sits at the bottom.

ALT The cannabis landscape is changing faster than ever. With hemp-derived products ubiquitous in the consumer market and federal rescheduling of cannabis to Schedule III reshaping access and regulation, there has never been a more important moment to take stock of where we are and where we are headed. The 2026 @UCLACannabis Center annual event wil discuss some of the most pressing topics in this area. Register here - spaces is limited! https://zoom.us/webinar/register/WN_onc2FTSdQmSfPYxbqoX_aA#/registration






















